Back to search results

Smoking Cessation Study for Cardiopulmonary Patients

This study is for patients admitted to Baystate Medical Center in Springfield, MA, with heart or lung conditions who smoke cigarettes and speak English. It aims to help people quit smoking after being in the hospital. You would be assigned to one of two groups: 1) Enhanced Usual Care (EUC): You'll get a referral to a state quitline, your doctor will be told about your quit attempt, and you'll receive assessment-only text messages. 2) Nurse Practitioner Tobacco Treatment Team (NPT3): You'll receive a more personalized, multi-part smoking cessation program in addition to usual care. The study wants to see if the NPT3 approach helps more people use recommended smoking cessation medicines 7 days after leaving the hospital and if it helps more people quit smoking after 6 months. The study is currently unclear on its status and plans to enroll 424 participants.

Study design
This study is an interventional trial that will randomly assign 424 participants to one of two groups.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 6 months after hospital discharge to check on smoking cessation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05733767

Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study

Recruiting
PHASE2Ages 18+InterventionalTreatment
Baystate Medical Center
~424 participants
Updated 2025-12-30 on ClinicalTrials.gov
What's tested:Enhanced Usual Care (EUC)Nurse Practitioner Tobacco Treatment Team (NPT3)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of patients using guideline concordant smoking cessation medication at 7 days
Measured over 7 days after hospital discharge
+1 more outcome measured

Conditions

Cardiopulmonary Disease
Smoking Cessation
Inpatient

Explore related trials

Acute Coronary SyndromeAortic Valve SurgeryAsthmaChronic Obstructive Pulmonary DiseaseCoronary Artery Bypass SurgeryCor PulmonaleHeart FailureMyocardial InfarctionPercutaneous Coronary Intervention

Where it's being run

1 sites across 1 states
Massachusetts1

Study leadership

  • Quinn R Pack, MD · PRINCIPAL_INVESTIGATOR · Baystate Medical Center

Who to contact

Quinn R Pack, MD
[email protected]
413-794-4490
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Admitted to Baystate Medical Center in Springfield, MA with a cardiac or pulmonary disease diagnosis will be eligible to participate in this trial.
Patients who smoke cigarettes
Speak English
myocardial infarction
coronary artery bypass grafting surgery
heart valve surgery
percutaneous coronary intervention (PCI)
acute coronary syndrome
heart failure
chronic obstructive pulmonary disease (COPD)
asthma exacerbation.

Exclusion

We will exclude pregnant or nursing women, patients with current suicidal ideation, planned discharge to hospice or expected survival \<6 months, or concurrent use of daily smoked marijuana, because this can increase exhaled carbon monoxide levels, which would confound biochemical confirmation.

What this trial measures

  • Proportion of patients using guideline concordant smoking cessation medication at 7 days7 days after hospital discharge

    Use of varenicline or combination medications (nicotine patch and lozenge, gum, or inhaler) on the 7th day after discharge

  • Proportion of patients reporting smoking cessation abstinence (7 day point prevalence at 6 months)7 day point prevalence at 6 months after hospital discharge

    Patients who have self-reported not using any tobacco products in the 7 days prior to assessment, then confirmed with an in-office exhaled carbon monoxide level of \<6 ppm.